CA1041909A - Pharmaceutical composition containing p-alkanoyltoluene - Google Patents

Pharmaceutical composition containing p-alkanoyltoluene

Info

Publication number
CA1041909A
CA1041909A CA220,658A CA220658A CA1041909A CA 1041909 A CA1041909 A CA 1041909A CA 220658 A CA220658 A CA 220658A CA 1041909 A CA1041909 A CA 1041909A
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
composition according
dosage form
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA220,658A
Other languages
English (en)
French (fr)
Other versions
CA220658S (en
Inventor
William J. Houlihan
Robert S. Ho
Jeffrey Nadelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1041909A publication Critical patent/CA1041909A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA220,658A 1974-02-25 1975-02-24 Pharmaceutical composition containing p-alkanoyltoluene Expired CA1041909A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44526574A 1974-02-25 1974-02-25
US49586274A 1974-08-08 1974-08-08

Publications (1)

Publication Number Publication Date
CA1041909A true CA1041909A (en) 1978-11-07

Family

ID=27034241

Family Applications (1)

Application Number Title Priority Date Filing Date
CA220,658A Expired CA1041909A (en) 1974-02-25 1975-02-24 Pharmaceutical composition containing p-alkanoyltoluene

Country Status (8)

Country Link
AU (1) AU500550B2 (xx)
CA (1) CA1041909A (xx)
DE (1) DE2506456A1 (xx)
FR (1) FR2261758B1 (xx)
GB (1) GB1504207A (xx)
IE (1) IE40941B1 (xx)
IL (1) IL46690A (xx)
NL (1) NL7502079A (xx)

Also Published As

Publication number Publication date
IL46690A0 (en) 1975-04-25
NL7502079A (nl) 1975-08-27
IE40941B1 (en) 1979-09-12
FR2261758B1 (xx) 1980-01-11
AU500550B2 (en) 1979-05-24
DE2506456A1 (de) 1975-08-28
IL46690A (en) 1977-07-31
IE40941L (en) 1975-08-25
FR2261758A1 (xx) 1975-09-19
AU7854575A (en) 1976-08-26
GB1504207A (en) 1978-03-15

Similar Documents

Publication Publication Date Title
KR910004572B1 (ko) 경구용 당뇨병 치료제 제형의 제조방법
RU1816213C (ru) Способ получени твердой лекарственной формы с регулируемым выделением лекарственного средства
US5674893A (en) Method for preventing reducing or risk of onset of cerebrovascular events employing an HMG CoA reductase inhibitor
US5487900A (en) Stabilized vitamin D preparation
US20060166959A1 (en) Pharmaceutical compositions based on azetidine derivatives
EP0231826A2 (en) Theophylline sustained release tablet
CA1298199C (en) Spray dried acetaminophen
EP1833466A1 (en) Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine
RU2006137330A (ru) Пероральные матричные композиции, содержащие ликарбазепин
CN1691947B (zh) 雌激素成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述雌激素成分的药物组合物
EP0455042A1 (en) Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
EP0671170A1 (en) Use of pravastatin for slowing progression coronary artery atherosclerosis
AU781828B2 (en) Dosing regimens for lasofoxifene
JP4212272B2 (ja) トリグリセリド低下剤組成物
EP0373507A1 (en) Combination of an HMG CoA reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
KR960007753B1 (ko) 피페리디노알칸올 유도체용 제약 조성물
CA1041909A (en) Pharmaceutical composition containing p-alkanoyltoluene
EP0521057B1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
CA1165241A (en) Sustained release theophylline tablet having reduced bulk
Shargel et al. Effect of antacid on bioavailability of theophylline from rapid and timed‐release drug products
WO2002038151A1 (fr) Compositions permettant de reduire la concentration de peroxydes lipidiques
CA1048934A (en) Organic compounds
US3968247A (en) Substituted or unsubstituted p-alkanoyl toluenes as anti-diabetic agents
JP4212271B2 (ja) 血中脂質改善剤組成物
US4146648A (en) Chemotherapeutic composition